A recombinant uricase for treatment of chronic gout refractory to conventional therapy

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2010年 / 45卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [41] Angina pectoris refractory for conventional therapy - Is neurostimulation a possible alternative treatment?
    Hautvast, RWM
    DeJongste, MJL
    TerHorst, GJ
    Blanksma, PK
    Lie, KI
    CLINICAL CARDIOLOGY, 1996, 19 (07) : 531 - 535
  • [42] Infliximab in the treatment of adult Still's disease refractory to conventional therapy
    Cavagna, L
    Caporali, R
    Epis, O
    Bobbio-Pallavicini, F
    Montecucco, C
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (03) : 329 - 332
  • [43] Reversal of chronic refractory tophaceous gout with erosions with pegloticase
    Yeter, Karen C.
    Ortiz, Elizabeth C.
    Arkfeld, Daniel G.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (03) : 369 - 370
  • [44] Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
    Herbert SB Baraf
    Michael A Becker
    Sergio R Gutierrez-Urena
    Edward L Treadwell
    Janitzia Vazquez-Mellado
    Claudia D Rehrig
    Faith D Ottery
    John S Sundy
    Robert A Yood
    Arthritis Research & Therapy, 15
  • [45] Efficacy but side effects of anakinra therapy for chronic refractory gout in a renal transplant recipient with preterminal chronic renal failure
    Direz, Guillaume
    Noel, Natacha
    Guyot, Charlotte
    Toupance, Olivier
    Salmon, Jean-Hugues
    Eschard, Jean-Paul
    JOINT BONE SPINE, 2012, 79 (06) : 631 - 631
  • [46] Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
    Baraf, Herbert S. B.
    Becker, Michael A.
    Gutierrez-Urena, Sergio R.
    Treadwell, Edward L.
    Vazquez-Mellado, Janitzia
    Rehrig, Claudia D.
    Ottery, Faith D.
    Sundy, John S.
    Yood, Robert A.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [47] DRUG THERAPY - TREATMENT OF GOUT
    GOLDFINGER, SE
    NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (23): : 1303 - +
  • [48] Clinical Efficacy Outcomes with up to 3 Years of Pegloticase Treatment for Refractory Chronic Gout.
    Becker, Michael A.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Dillon, Aileen M.
    Vazquez-Mellado, Janitzia
    Ottery, Faith D.
    Khanna, Dinesh
    Sundy, John S.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S69 - S69
  • [49] Uricosuric therapy for chronic tophaceous gout
    Calabozo, M
    Perez-Ruiz, F
    Alonso-Ruiz, A
    Herrero-Beites, A
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S151 - S151
  • [50] ASSOCIATION OF RENAL DYSFUNCTION AND DEVELOPMENT OF TOPHI IN SUBJECTS WITH CHRONIC REFRACTORY GOUT AND RESPONSE TO TREATMENT WITH PEGLOTICASE
    Edwards, N. L.
    Singh, J.
    Troum, O.
    Yeo, A.
    Lipsky, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1049 - 1049
12345